dc.contributor.author | Rowen, Robert Jay | |
dc.contributor.author | Robins, Howard | |
dc.date.accessioned | 2020-04-21T03:21:42Z | |
dc.date.available | 2020-04-21T03:21:42Z | |
dc.date.issued | 2020-03 | |
dc.identifier.uri | https://globalent.co.za/wp-content/uploads/2020/03/Corona-Published-1.pdf | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/1127 | |
dc.description.abstract | Many viruses require reduced sulfhydryl groups for cell fusion and entry. Corona viruses, including SARS-CoV-2 (the cause of the condition now named coronavirus disease 2019 or COVID-19), are rich in cysteine, which residues must be intact for viral activity. Sulfhydryl groups are vulnerable to oxidation. Ozone therapy, a very inexpensive and safe modality may safely exploit this critical vulnerability in many viruses, inclusive of SARS-CoV-2. | en_US |
dc.language | English | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Ozone | en_US |
dc.subject | Antiviral Agents | en_US |
dc.subject | Therapeutics | en_US |
dc.title | A Plausible Penny Costing Effective Treatment for Corona Virus - Ozone Therapy | en_US |
eihealth.country | United States | en_US |
eihealth.category | Candidate therapeutics RD | en_US |
eihealth.type | Published Article | en_US |
eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
dc.relation.ispartofjournal | Journal of Infectious Diseases and Epidemiology | en_US |